Compare Microchip Technology Inc. (MCHP) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Microchip Technology Inc. trades at $77 (market cap $42.37B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Microchip Technology Inc. is far larger — about 18.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Microchip Technology Inc. pays a 2.33% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| MCHP | SLS | |
|---|---|---|
Market Cap | $42.37B | $2.28B |
Volume | 8,887,625 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $102.97 | $15.46 |
52-Week Low | $49.02 | $1.39 |
Typical Hold Time | 62 Days | — |
Enterprise Value | $47.49B | $2.15B |
Dividend Yield | 2.33% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MCHP trades at $75.52, down 7.06% over 24 hours amid a bearish technical signal. The company reported a net loss of -$500K for 2025, though it has beaten EPS estimates for the last three quarters. Analyst consensus is strongly bullish with a $110.50 price target, and recent news highlights expansion in Ethernet and 48V power portfolios, plus the completed acquisition of Hailo to bolster edge AI capabilities.
The outlook is mixed: strong analyst support and strategic acquisitions in growth areas like AI and data centers present upside, but high valuation ratios, significant debt, and recent profitability challenges pose risks. The stock's near-term performance will hinge on Q3 2026 earnings and execution in high-demand semiconductor segments.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
